Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Particularly funny was that medical regulators will be gumshoeing through anonymous MB posts to make their decisions. If they do happen to do so, they will be asking for personal contact information for all such posters and contacting them. This could lead to very embarrassing exposure for some anonymous MB posters pretending to be white knights saving poor retail by throwing around lurid allegations of wrongdoing and outright criminal activity. Such exposure will likely to lead to a criminal referral to the appropriate authorities in their home country of record.
Now we know why there is an Adderall shortage.
Not necessarily, just filing at the deadline. We have submitted proposals close to the deadline even though they were ready before it.
And for those who keep pointing to potential differences in SOP to produce the vaccine, a research hospital will not, and probably cannot due to costs, be using the same facilities/equipment as a commercial enterprise.
Whatever your opinions, the fact that the text appears in the 10-K, as it has for the last many years, is not a sign of anything. They just left the boilerplate risk language alone. You are overthinking it.
Philanthrowashing, to coin a term, his reputation?
Perhaps he is Adam.
I suspect this is the result of AF, a proxy, or even an NVCR vested doctor doing some gumshoeing in the UK, similar to another complaint that was filed against NWBO about premature marketing, finding this individual and then getting them to file a complaint and create a smokescreen, which is the essence of F.U.D. I am sure we remember the FUD created by AF, by innuendo, about LL's withdrawal from the NYSCR presentation in May 2022. A smokescreen-based FUD near an impending major milestone is just his style.
The first sentence says '...histology consistent with glioblastoma'. The rest of the document snippet raises the issue of a possible misdiagnosis and as you said, there is no connection to NWBO's DCVAX-L or the trial. Based on the two snippets provided, and one appears to be related to reimbursement for travel expenses, this appears, at most, to be raising a malpractice issue. But, given the first sentence, that may also be doubtful.
Yes. I noticed that LC is jumping on every positive post to try and pooh-pooh and discredit it.
Ahhh. There it is - the altruistic motivation to save us from committing financial hara-kiri.
BTW, your statement that you were not involved with the US company is irrelevant since they were sponsoring the trial and it was executed with the same protocols worldwide. So, whatever you are claiming happened ends up as the responsibility of the US Company. So, all your innuendos are being pointed at them. If you are wrong and they decide to take action, you are looking down the barrel of a defamation lawsuit. Anonymous postings do not prevent them from getting your information from iHub for legal action.
I was thinking the same thing. the FT article elicited a tweXt from AF and a new poster shows up with a strange story of being 'selected' for therapy without consent for a trial that was not a noble effort. All innuendo. As they say in some circles, all hat and no cattle.
In combination with your earlier post that the trial wasn't the noble effort it is made out to be, are you insinuating that the trial was 'selecting' non-GBM patients and presenting them as GBM and then using their longevity to skew the trial results? Hoo boy. You better have a lot of data to defend that position.
It's late to be still working your street corner.
Great self awareness.
IMO, strong possibility that they file for an extension and wait to see what MHRA says after the 80-day assessment phase.
Is it coincidental that the 'next week or so' in the NICE communication aligns with the end of the 80-day phase of the MHRA 150-day process?
If there is one, does NWBO need to PR that fact or is there some other way we can learn whether that happened or not?
Nope. Your posting record is replete with continuous retreats as listed by Flipper.
The other argument that is being laid down is that it is just the UK. The FDA, Canada, etc., will not approve because the trial was flawed and that is why they went to the UK. That was slipped into a fudster's post.
Are there aliens at Area 51? can you answer that?
JSK - the one associated with the Phase V report that ran with the disclaimer that anything we say here may not be true?
Riveting commentary as always. /s
And yet, here you are posting your BS incessantly. Is it altruism or some nefarious goal?
I recall that as well. I believe reimbursement may be available for an approved therapy and NICE approval was more than six months away?
The paloma would be an appropriate cocktail for such a gathering. 😁
BS.FUD. It does not matter that any biotech would not announce a submission. The MHRA cannot confirm or deny until the biotech has done so. MHRA cannot front-run the announcement. Effing simple logic.
Hopefully, they research any COI carefully before getting the experts' opinion. As we have seen there were comments on NWBO's JAMA paper by 'experts' who were not fully forthcoming on their COI. It appeared some of them omitted affiliations that would indicate significant COI.
It is as though they are being bottle-fed their fud at a fudster factory, right?
And you are here, why?
Always great to get these positive updates from patients, especially where strangers from around the world have responded to fundraisers to help out with finances and implicit moral support.
Flipper44: I probably missed the discussion of what constitutes 'cementing the MAA' means. Would it be if the CHM meeting happens and there are no further questions? Thanks.
Flipper,
That is a pretty compelling set of dots that have connected.